Wednesday, June 10, 2020 9:27:54 AM
Recent AWH News
- Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® • GlobeNewswire Inc. • 11/07/2024 01:00:00 PM
- Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 • GlobeNewswire Inc. • 11/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 08:45:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2024 10:54:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2024 10:47:01 PM
- Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 • GlobeNewswire Inc. • 10/25/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 12:00:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 05:29:26 PM
- Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health • GlobeNewswire Inc. • 10/23/2024 03:23:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2024 08:00:39 PM
- Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® • GlobeNewswire Inc. • 10/15/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 08:44:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 10:05:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 09:55:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 09:39:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 09:31:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 09:19:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 09:09:35 PM
- Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass • GlobeNewswire Inc. • 09/10/2024 12:00:00 PM
- Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2024 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/05/2024 08:02:38 PM
- Aspira Women’s Health Selected as a Spoke for the Investor Catalyst Hub • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/04/2024 04:15:09 AM
- Aspira Women’s Health Partners with Dorsata to Create New Clinical Workflow Tool for Adnexal Masses • GlobeNewswire Inc. • 08/27/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 08:42:10 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM